The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Macrolide resistance
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Resistance to the other MLS-B requires the presence of an inducer, which may be erythromycin or another macrolide M14-15 [104].”
From Molecular Mechanisms of Drug Resistance in Staphylococcus aureus (2022) · cites this paper as [104]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hagman, K. E., Spratt, B. G., Balthazar, J. T., Pan, W., Judd, R. C., & Shafer, W. M. (1995) · Microbiology · doi:10.1099/13500872-141-3-611 · Cited by 368
Research works printed but not linked: 87
- Arthur, 1987, Distribution of erythromycin esterase and rRNA methylase genes in members of the family Enterobacteriaceae highly resistant to erythromycin, Antimicrobial Agents Chemother, 31, 404, 10.1128/AAC.31.3.404 · DOI
- Ounissi, 1985, Nucleotide sequence of the gene ereA encoding the erythromycin esterase in Escherichia coli, Gene, 35, 271, 10.1016/0378-1119(85)90005-8 · DOI
- Wondrack, 1996, Clinical strain of Staphylococcus aureus inactivates and causes efflux of macrolides, Antimicrobial Agents Chemother, 40, 992, 10.1128/AAC.40.4.992 · DOI
- Cundliffe, 1992, Glycosylation of macrolide antibiotics in extracts of Streptomyces lividans, Antimicrobial Agents Chemother, 36, 348, 10.1128/AAC.36.2.348 · DOI
- Vilches, 1992, Role of glycosylation and deglycosylation in biosynthesis of and resistance to oleandomycin in the producer organism, Streptomyces antibioticus, J Bacteriol, 174, 161, 10.1128/jb.174.1.161-165.1992 · doi:10.1128/jb.174.1.161-165.1992
- Ohara, 1989, Purification and characterization of macrolide 2′-phosphotransferase from a strain of E. coli that is highly resistant to erythromycin, Antimicrobial Agents Chemother, 33, 1354, 10.1128/AAC.33.8.1354 · DOI
- Kono, 1992, Purification and characterization of macrolide 2′-phosphotransferase type II from a strain of Escherichia coli highly resistant to macrolide antibiotics, FEMS Microbiol Lett, 76, 89
- Noguchi, 1996, Cloning and nucleotide sequence of the mphB gene for macrolide 2′-phosphotransferase II in Escherichia coli, FEMS Microbiol Lett, 144, 197
- Kim, 1996, Nucleotide sequence expression and transcriptional analysis of the Escherichia coli mphK gene encoding macrolide phosphotransferase, Molecules Cells, 6, 153, 10.1016/S1016-8478(23)10983-6 · doi:10.1016/s1016-8478(23)10983-6
- Birmingham, 1986, Cloning and expression of a tylosin resistance gene from a tylosin-producing strain of Streptomyces fradiae, Mol Gen Genet, 204, 532, 10.1007/BF00331036 · DOI
- Richardson, 1987, A new shuttle cosmid vector, pKC505, for streptomycetes: its use in the cloning, of three different spiramycin-resistance genes from a Streptomyces ambofaciens library, Gene, 61, 231, 10.1016/0378-1119(87)90187-9 · DOI
- Weisblum, 1995, Erythromycin resistance by ribosome modification, Antimicrobial Agents Chemother, 39, 577, 10.1128/AAC.39.3.577 · DOI · Paper page
- Weisblum, 1995, Insights into erythromycin action from studies of its activity as inducer of resistance, Antimicrobial Agents Chemother, 39, 797, 10.1128/AAC.39.4.797 · DOI · Paper page
- Noller, 1981, Secondary structure model for 23S ribosomal RNA, Nucleic Acids Res, 9, 6167, 10.1093/nar/9.22.6167 · DOI · Paper page
- Skinner, 1983, Site of action of a ribosomal RNA methylase responsible for resistance to erythromycin and other antibiotics, J Biol Chem, 258, 12702, 10.1016/S0021-9258(17)44232-3 · DOI · Paper page
- Gryczan, 1980, Conformational alteration of mRNA structure and the posttranscriptional regulation of erythromycin-induced drug resistance, Nucleic Acids Res, 8, 6081, 10.1093/nar/8.24.6081 · DOI · Paper page
- Kwak, 1991, Transcriptional attenuation control of ermK, a macrolide-lincosamide-streptogramin B resistance determinant from Bacillus licheniformis, J Bacteriol, 173, 4725, 10.1128/jb.173.15.4725-4735.1991 · DOI
- Allen, 1977, Macrolide resistance in Staphylococcus aureus: inducers of macrolide resistance, Antimicrobial Agents Chemother, 11, 669, 10.1128/AAC.11.4.669 · DOI
- Kamimiya, 1997, Induction of ermSV by 16-membered ring macrolides, Antimicrobial Agents Chemother, 41, 530, 10.1128/AAC.41.3.530 · DOI
- Jenkins, 1991, Cloning and characterization of two genes from Streptomyces lividans that confer inducible resistance to lincomycin and macrolide antibiotics, Gene, 108, 55, 10.1016/0378-1119(91)90487-V · DOI
- Memili, 1997, Essential role of endogenously synthesized tylosin for induction of ermSF in Streptomyces fradiae, Antimicrobial Agents Chemother, 41, 1203, 10.1128/AAC.41.5.1203 · doi:10.1128/aac.41.5.1203
- Meier, 1994, Identification of mutations in the 23S ribosomal RNA gene of clarithromycin resistant Mycobacterium intracellulare, Antimicrobial Agents Chemother, 38, 381, 10.1128/AAC.38.2.381 · DOI · Paper page
- Desmyter, 1968, Lincomycin resistance of erythromycin-resistant cocci, N Engl J Med, 278, 967, 10.1056/NEJM196804252781720 · doi:10.1056/nejm196804252781720
- Watanakunakorn, 1976, Clindamycin therapy of Staphylococuus aureus endocarditis. Clinical relapse and development of resistance to clindamycin, lincomycin, and erythromycin, Am J Med, 60, 419, 10.1016/0002-9343(76)90758-0 · DOI · Paper page
- Leclercq, 1991, Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification, Antimicrobial Agents Chemother, 35, 1267, 10.1128/AAC.35.7.1267 · DOI · Paper page
- Mazzei, 1993, Chemistry and mode of action of macrolides, J Antimicrob Chemother, 31, 1, 10.1093/jac/31.suppl_C.1 · DOI · Paper page
- Ross, 1997, Clinical resistance to erythromycin and clindamycin in cutaneous Propionibacteria isolated from patients is associated with mutations in 23S rRNA Antimicrobial Agents Chemother, 41, 1162
- Versalovic, 1996, Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori, Antimicrobial Agents Chemother, 40, 477, 10.1128/AAC.40.2.477 · DOI · Paper page
- Pernodet, 1988, Resistance to macrolides, lincosamides and streptogramin type B antibiotics due to a mutation in an rRNA operon of Streptomyces ambofaciens, EMBO J, 7, 277, 10.1002/j.1460-2075.1988.tb02810.x · DOI
- Pernodet, 1989, Organization and nucleotide sequence analysis of a ribosomal RNA gene cluster from Streptomyces ambofaciens, Gene, 79, 33, 10.1016/0378-1119(89)90090-5 · DOI
- Dam, 1996, Mutations in domain II of 23S rRNA facilitate translation of a 23S rRNA-encoded pentapeptide conferring erythromycin resistance, J Mol Biol, 259, 1, 10.1006/jmbi.1996.0296 · DOI
- Tenson, 1997, Erythromycin resistance peptides selected from random peptide libraries, J Biol Chem, 272, 17425, 10.1074/jbc.272.28.17425 · DOI
- Lewis, 1994, Multidrug resistance pumps in bacteria: variations on a theme, Trends Biochem Sci, 19, 119, 10.1016/0968-0004(94)90204-6 · DOI · Paper page
- Dinh, 1994, A family of extracytoplasmic proteins that allow transport of large molecules across the outer membranes of gram-negative bacteria, J Bacteriol, 176, 3825, 10.1128/jb.176.13.3825-3831.1994 · DOI · Paper page
- Paulsen, 1996, Proton-dependent multidrug efflux systems, Microbiol Rev, 60, 575, 10.1128/MMBR.60.4.575-608.1996 · doi:10.1128/mmbr.60.4.575-608.1996 · Paper page
- Sutcliffe, 1996, Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system, Antimicrobial Agents Chemother, 40, 1817, 10.1128/AAC.40.8.1817 · DOI · Paper page
- Clancy, 1996, Molecular cloning and functional analysis of a novel macrolide resistance determinant, MEFA, from Streptococcus pyogenes, Mol Microbiol, 22, 867, 10.1046/j.1365-2958.1996.01521.x · DOI · Paper page
- Tait-Kamradt, 1997, mefE is necessary for the erythromycin-resistant M phenotype in Streptococcus pneumoniae, Antimicrobial Agents Chemother, 41, 2251, 10.1128/AAC.41.10.2251 · DOI · Paper page
- Ross, 1989, Characterisation and molecular cloning of the novel macrolide-streptogramin B resistance determinant from Staphylococcus epidermidis, J Antimicrobial Chemother, 24, 851, 10.1093/jac/24.6.851 · DOI
- Ross, 1990, Inducible erythromycin resistance in staphylococci is encoded by a member of the ATP-binding transport super-gene family, Mol Microbiol, 4, 1207, 10.1111/j.1365-2958.1990.tb00696.x · DOI · Paper page
- Ross, 1996, Minimal functional system required for expression of erythromycin resistance by MSRA in Staphylococcus aureus RN4220, Gene, 183, 143, 10.1016/S0378-1119(96)00541-0 · doi:10.1016/s0378-1119(96)00541-0
- Jánosi, 1990, Characterization of plasmids that confer inducible resistance to 14-membered macrolides and streptogramin type B antibiotics in Staphylococcus aureus, Microbiol Immunol, 34, 723, 10.1111/j.1348-0421.1990.tb01050.x · DOI
- Matsuoka, 1995, A mechanism of resistance to partial macrolide and streptogramin B antibiotics in Staphylococcus aureus clinically isolated in Hungary, Biol Pharm Bull, 18, 1482, 10.1248/bpb.18.1482 · doi:10.1248/bpb.18.1482
- Matsuoka, 1997, A dyadic plasmid that shows MLS and PMS resistance in Staphyloccus aureus, FEMS Microbiol Lett, 148, 91, 10.1111/j.1574-6968.1997.tb10272.x · doi:10.1111/j.1574-6968.1997.tb10272.x
- Nakajima, 1992, Inducible resistance to a 16-membered macrolide, mycinamicin, in Staphylococcus aureus resistant to 14-membered macrolides and streptogramin B antibiotics, J Pharmacobio-Dynamics, 15, 319, 10.1248/bpb1978.15.319 · doi:10.1248/bpb1978.15.319
- Rosteck, 1991, Homology between proteins controlling Streptomycs fradiae tylosin resistance and ATP-binding transport, Gene, 102, 27, 10.1016/0378-1119(91)90533-H · DOI
- Epp, 1987, Cloning and nucleotide sequence of a carbomycin-resistance gene from Streptomyces thermotolerans, Gene, 53, 73, 10.1016/0378-1119(87)90094-1 · DOI
- Schoner, 1992, Sequence similarity between macrolide-resistance determinants and ATP-binding proteins, Gene, 115, 93, 10.1016/0378-1119(92)90545-Z · DOI
- Aparicio, 1996, Characterization of the ATPase activity of the N-terminal nucleotide binding domain of an ABC transporter involved in oleandomycin secretion by Streptomyces antibioticus, FEMS Microbiology Lett, 141, 157, 10.1111/j.1574-6968.1996.tb08378.x · DOI
- Edgar, 1997, MDFA, an Escherichia coli multidrug resistance protein with an extraordinarily broad spectrum of drug recognition, J Bacteriol, 179, 2274, 10.1128/jb.179.7.2274-2280.1997 · DOI · Paper page
- Jäger, 1997, A Corynebacterium glutamicum resistance protein conferring multidrug resistance in the heterologous host Escherichia coli, J Bacteriol, 179, 2449, 10.1128/jb.179.7.2449-2451.1997 · DOI
- Sanchez, 1997, The acrAB homolog of Haemophilus influenzae codes for a functional multidrug efflux pump, J Bacteriol, 179, 6855, 10.1128/jb.179.21.6855-6857.1997 · DOI
- Choi, 1997, Role of mRNA termination in regulation of ermK, J Bacteriol, 179, 2065, 10.1128/jb.179.6.2065-2067.1997 · DOI
- Yanofsky, 1988, Transcription attenuation, J Biol Chem, 263, 609, 10.1016/S0021-9258(19)35394-3 · doi:10.1016/s0021-9258(19)35394-3
- Weisblum, 1971, Erythromycin-inducible resistance in Staphylococcus aureus: requirements for induction, J Bacteriol, 106, 835, 10.1128/JB.106.3.835-847.1971 · DOI
- Tai, 1974, Selective action of erythromycin on initiating ribosomes, Biochemistry, 13, 4653, 10.1021/bi00719a029 · DOI
- Menninger, 1982, Erythromycin, carbomycin, and spiramycin, inhibit protein synthesis by stimulating the dissociation of peptidyl-tRNA from ribosomes, Antimicrobial Agents Chemother, 21, 811, 10.1128/AAC.21.5.811 · DOI
- Sandler, 1989, Erythromycin-induced ribosome stall in the ermA leader: a barricade to 5′-to-3′ nucleolytic cleavage of the ermA transcript, J Bacteriol, 171, 6680, 10.1128/jb.171.12.6680-6688.1989 · DOI
- Mayford, 1989, Conformational alterations in the ermC transcript in vivo during induction, EMBO J, 8, 4307, 10.1002/j.1460-2075.1989.tb08617.x · DOI
- Mayford, 1989, ermC leader peptide, amino acid sequence critical for induction by translational attenuation, J Mol Biol, 206, 69, 10.1016/0022-2836(89)90524-X · DOI
- Mayford, 1990, The ermC leader peptide: amino acid alterations leading to differential efficiency of induction by macrolide-lincosamide-streptogramin B antibiotics, J Bacteriol, 172, 3772, 10.1128/jb.172.7.3772-3779.1990 · DOI
- Lovett, 1996, Ribosome regulation by the nascent peptide, Microbiol Revs, 60, 366, 10.1128/MMBR.60.2.366-385.1996 · doi:10.1128/mmbr.60.2.366-385.1996 · Paper page
- Tanaka, 1974, Mutant of Staphylococcus aureus with lincomycin- and carbomycin-inducible resistance to erythromycin, Antimicrobial Agents Chemother, 5, 538, 10.1128/AAC.5.5.538 · doi:10.1128/aac.5.5.538
- Garrod, 1957, The erythromycin group of antibiotics, Br Med J, 2, 57, 10.1136/bmj.2.5036.57 · DOI
- Saito, 1971, Antibacterial activity of megalomicin and its inducer activity for macrolide resistance in Staphylococci, J Antibiot, 24, 850, 10.7164/antibiotics.24.850 · doi:10.7164/antibiotics.24.850
- Bourse, 1967, Effet de l'erythromycin sur la croissance de Staph. aureus resistant dissocié en bacteriostase par un autre macrolide ou un antibiotique apparenté, Ann de l'Inst Pasteur (Paris), 113, 67
- Chabbert, 1956, Antagonisme in vitro entre l'erythromycine et la spiramycine, Ann Inst Pasteur (Paris), 90, 787
- Dubnau, 1984, Translational attenuation: the regulation of bacterial resistance to the macrolide-lincosamide-streptogramin B antibiotics, CRC Crit Rev Biochem, 16, 103, 10.3109/10409238409102300 · DOI · Paper page
- Farmer, 1992, Influence of outer membrane mutations on susceptibility of Escherichia coli to the dibasic macrolide azithromycin, J Antimicrob Chemother, 29, 27, 10.1093/jac/29.1.27 · DOI
- Vaara, 1993, Outer membrane permeability barrier to azithromycin, clarithromycin, and roxithromycin in gram-negative enteric bacteria, Antimicrob Agents Chemother, 37, 354, 10.1128/AAC.37.2.354 · DOI · Paper page
- Bonnefoy, 1997, Ketolides lack inducibility properties of MLS(B) resistance phenotype, J Antimicrob Chemother, 40, 85, 10.1093/jac/40.1.85 · DOI · Paper page
- Jones, 1997, Antimicrobial activity of RU-66647, a new ketolide, Diag Microbiol Infect Dis, 27, 7, 10.1016/S0732-8893(96)00181-2 · doi:10.1016/s0732-8893(96)00181-2
- Clancy, 1995, Assays to detect and characterize synthetic agents that inhibit the ErmC methyltransferase, J Antibiotics, 48, 1273, 10.7164/antibiotics.48.1273 · doi:10.7164/antibiotics.48.1273
- Yu, 1997, Solution structure of an rRNA methyltransferase (ErmAM) that confers MLS antibiotic resistance, Nature Struct Biol, 4, 483, 10.1038/nsb0697-483 · DOI
- Horinouchi, 1983, A complex attenuator regulates inducible resistance to macrolides, lincosamides, and streptogramin type B antibiotics in Streptococcus sanguis, J Bacteriol, 154, 1252, 10.1128/JB.154.3.1252-1262.1983 · DOI
- Kovalic, 1995, Methylation of minimalist 23S rRNA sequences in vitro by ErmSF (TlrA) N-methyltransferase, Biochemistry, 34, 15838, 10.1021/bi00048a029 · DOI
- Vester, 1994, Domain V of 23S rRNA contains all the structural elements necessary for recognition by the ErmE methyltransferase, J Bacteriol, 176, 6999, 10.1128/jb.176.22.6999-7004.1994 · doi:10.1128/jb.176.22.6999-7004.1994
- Kovalic, 1994, 23S rRNA domain V, a fragment that can be specifically methylated in vitro by the ErmSF (TlrA) methyltransferase, J Bacteriol, 176, 6992, 10.1128/jb.176.22.6992-6998.1994 · DOI
- Oliynyk, 1996, A hybrid modular polyketide synthase obtained by domain swapping, Chem Biol, 3, 833, 10.1016/S1074-5521(96)90069-1 · DOI
- Ruan, 1997, Acyltransferase domain substitutions in erythromycin polyketide synthase yield novel erythromycin derivatives, J Bacteriol, 179, 6416, 10.1128/jb.179.20.6416-6425.1997 · DOI
- Fu, 1996, Antibiotic activity of polyketide products derived from combinatorial biosynthesis: implications for directed evolution, Molecular Diversity, 1, 121, 10.1007/BF01721327 · doi:10.1007/bf01721327
- Horinouchi, 1981, The control region for erythromycin resistance: free energy changes related to induction and mutation to constitutive expression, Mol Gen Genet, 182, 341, 10.1007/BF00269681 · doi:10.1007/bf00269681
- Hodel, 1996, The 1.85 angstrom structure of vaccinia protein VP39: a bifunctional enzyme that participates in the modification of both mRNA ends, Cell, 85, 247, 10.1016/S0092-8674(00)81101-0 · DOI · Paper page
- Monod, 1987, Cloning and analysis of ermG, a new macrolide-lincosamide-streptogramin B resistance element from Bacillus sphaericus, J Bacteriol, 169, 340, 10.1128/jb.169.1.340-350.1987 · DOI
- Kamimiya, 1988, Translational attenuation control of ermSF, an inducible resistance determinant encoding rRNA N-methyltransferase from Streptomyces fradiae, J Bacteriol, 170, 1800, 10.1128/jb.170.4.1800-1811.1988 · DOI
- Hodgson, 1990, Nucleotide sequence of the erythromycin resistance gene from the Corynebacterium plasmid pNG2, Nucleic Acids Res, 18, 1891, 10.1093/nar/18.7.1891 · DOI
- Dahl, 1994, A series of integrative plasmids for Bacillus subtilis containing unique cloning sites in all three open reading frames for translational lacZ fusions, Gene, 145, 151, 10.1016/0378-1119(94)90341-7 · doi:10.1016/0378-1119(94)90341-7
Cited by
Molecular Mechanisms of Antibacterial Multidrug Resistance
Alekshun, M. N., & Levy, S. B. (2007) · Cell · doi:10.1016/j.cell.2007.03.004 · Cited by 1,647
Nomenclature for Macrolide and Macrolide-Lincosamide-Streptogramin B Resistance Determinants
Roberts, M. C., Sutcliffe, J., Courvalin, P., Jensen, L. B., Rood, J., & Seppala, H. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.12.2823 · Cited by 874
Macrolide Resistance Conferred by Base Substitutions in 23S rRNA
Vester, B., & Douthwaite, S. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.1.1-12.2001 · Cited by 556
Molecular Detection of Antimicrobial Resistance
Fluit, A. C., Visser, M. R., & Schmitz, F.-J. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.4.836-871.2001 · Cited by 525
Antimicrobial resistance, mechanisms and its clinical significance
Abushaheen, M. A., Muzaheed, Fatani, A. J., Alosaimi, M., Mansy, W., George, M., Acharya, S., Rathod, S., Divakar, D. D., Jhugroo, C., et al. (2020) · Disease-a-Month · doi:10.1016/j.disamonth.2020.100971 · Cited by 511
Metadata
- Authors
- Weisblum, B.
- Venue
- Drug Resistance Updates
- Publisher
- Elsevier BV
- Published
- 1998-03
- Volume
- 1
- Issue
- 1
- Pages
- 29-41
- ISSN
- 1368-7646
- Cited by
- 87
- References
- 1
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Macrolide resistance. https://app.cochat.ai/papers/10.1016/s1368-7646(98)80212-4
- The paper
- Weisblum, B. (1998). Macrolide resistance. Drug Resistance Updates. https://doi.org/10.1016/s1368-7646(98)80212-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.